Related Articles
Epidermal growth factor receptor and KRAS mutations in lung adenocarcinoma: A retrospective study of the Lebanese population
Differences in EGFR and KRAS mutation spectra in lung adenocarcinoma of never and heavy smokers
Prognostic significance of combining VEGFA, FLT1 and KDR mRNA expression in lung cancer
Epidermal growth factor receptor mutation enhances expression of vascular endothelial growth factor in lung cancer
Investigation of the epidermal growth factor receptor mutation rate in non‑small cell lung cancer patients and the analysis of associated risk factors using logistic regression